BioCentury
ARTICLE | Clinical News

Morphine sulphate regulatory update

October 18, 2004 7:00 AM UTC

Ethypharm announced marketing approval in Denmark of its once-a-day morphine sulfate to treat moderate to severe pain in patients who require continuous, around-the-clock opioid therapy for an extend...